Regulating the prices and costs of medicines in the United Kingdom

Journal of Pharmaceutical Finance, Economics and Policy

Volumn 12, Issue 3, 2003, Pages 235-260

  Taylor, David ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Control; Cost; Pharmaceutical; Regulation; UK

Indexed keywords

BUDGET; COST CONTROL; DRUG COST; HEALTH CARE POLICY; NATIONAL HEALTH SERVICE; PRIORITY JOURNAL; REVIEW; UNITED KINGDOM;

EID: 4744365714     PISSN: 15385698     EISSN: None     Source Type: Journal    
DOI: 10.1300/J371v12n03_03     Document Type: Review

References (22)

1. Pharmaceutical Industry Competitiveness Task Force. Final Report-March 2001. Department of Health Home Page. URL: http://www.doh.gov.uk/pictf.
2. Oxfam. Drug industry price life saving medicines beyond reach of the poor. Press release 12 February 2001. Oxfam, Oxford.
3. Taylor DG. Poor world health and rich world health. Br Med J. 2001; 322: 629-30.
4. HMSO. Report of the Committee of Enquiry into the Relationship of the Pharmaceutical Industry with the National Health Service 1965-67. London: HMSO, 1967; Cmnd 3410.
5. Audit Commission. What the Doctor Ordered: A Study of GP Fund-Holding in England and Wales. London: HMSO, 1996.
6. Department of Health. Pharmacy in the Future: Implementing the NHS Plan. London: Department of Health, 2000.
7. Department of Health. The Pharmaceutical Price Regulation Scheme. London: Department of Health. 1999.
8. Association of the British Pharmaceutical Industry. Understanding the PPRS. London: ABPI, 1999.
9. Walley T, Earl-Slater A. Haycox A et al. An integrated national pharmaceutical policy for the United Kingdom. Br Med J. 2000; 321:1523-6.
10. Health Select Committee. The Cost and Availability of Generic Drugs to the NHS. London: Stationary Office, 1999.
11. Walley T, Burrill P. Generic prescribing: Time to regulate the market? Br Med J. 2000; 320:131-2.
12. Taylor D, Maynard A. Medicines, the NHS and Europe. London: The King's Fund Institute; 1990.
13. Department of Health. The NHS Plan. London: The Stationary Office, 2000.
14. Ryan M, Birch S. Charging for health care: Evidence on the utilisation of NHS prescription drugs. Soc Sci Med. 1991; 33(6):681-7.
15. Hughes D, Maguire A. Patient charges and the utilisation of NHS prescription medicines: Some estimates using a cointegration procedure. Health Econ. 1995; 4:213-20.
16. Baines DL, Tolley KH, Whynes DK. Prescribing. Budgets and Fund-Holding in General Practice. London: OHE; 1997.
17. Gosden T, Torgerson DT. The Effect of Fund-Holding on Prescribing and Referral costs: A Review of the Evidence. Manchester: The National Primary Care Research and Development Centre; 1997.
18. Bateman DN, Campbell M, Donaldson LJ et al. A prescribing incentive scheme for non-fund-holding general practices: An observational study. Br Med J. 1996; 313:535-8.
19. Maynard A. Personal communication. 2001.
20. Sculpher M, Drummond M, O'Brien B. Effectiveness, efficiency, and NICE. Br Med J. 2001; 322:943-4.
21. Harrison A (2003). Getting the Right Medicines? Putting Public Interests at the Heart of Health-Related Research. The King's Fund, London.
22. Department of Health (2003). Pharmaceutical Price Regulation Scheme Discussion Paper. URL:http://www.doh.gov.uk/ppr/pprs/discussion.htm. Last accessed December 2003.